Skip to Content

IP 254 (Ranitidine 300 mg)

Pill imprint IP 254 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; zollinger-ellison syndrome; erosive esophagitis; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254  Front
Ranitidine hydrochloride 300 mg IP 254  Back
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride 300 mg IP 254
Ranitidine hydrochloride
Imprint:
IP 254
Strength:
300 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Amneal Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide